TEAD3 Transcription Factor: From Molecular Features to Disease Relevance

TEAD3 Transcription Factor: From Molecular Features to Disease Relevance—Powered by ANT BIO PTE. LTD.
 

1. Concept
TEAD3, a key member of the TEAD transcription factor family, boasts unique structural traits and precise DNA recognition capabilities. It features a highly conserved ~70-amino-acid TEA domain that folds into a distinctive "cloverleaf-like" structure, enabling specific binding to genomic MCAT elements (5'-CATTCC-3').

X-ray crystallography reveals that TEAD3’s DNA-binding interface differs subtly from TEAD1/2, with the lysine residue at position 52 being critical for recognition specificity. Its C-terminal region contains a canonical YAP/TAZ-binding domain, forming a hydrophobic pocket essential for transcriptional activity via coactivator interactions. Cryo-EM studies show the TEAD3-YAP complex has a unique spatial conformation, with a 5–7-degree binding angle difference from TEAD1/2 complexes—explaining its functional specificity. TEAD3 undergoes post-translational modifications including S-palmitoylation (at Cys359, a site distinct from other TEADs), phosphorylation, and SUMOylation, which dynamically regulate its nucleocytoplasmic shuttling, stability, and transcriptional activity. This unique palmitoylation site offers opportunities for developing specific targeted drugs.

2. Research Frontiers
TEAD3 research is advancing across reproductive biology, oncology, and neuroscience. A key frontier is deciphering its tissue-specific dual roles in cancer—oncogenic in gynecological cancers vs. tumor-suppressive in colorectal and certain lung cancers—using single-cell multi-omics to map cell-type-specific regulatory networks.

In reproductive medicine, studies focus on TEAD3’s role in placental development, with potential applications in treating preeclampsia and recurrent miscarriage. In neuroscience, emerging research explores its involvement in neural development and neuropsychiatric/neurodegenerative diseases.

Therapeutically, structure-guided drug design targets TEAD3’s unique palmitoylation pocket (Cys359) to develop selective inhibitors. Peptide inhibitors blocking TEAD3-YAP/ERα interactions and gene therapy (ASOs, siRNA) are also being explored. AI-powered virtual screening accelerates inhibitor discovery, while tissue-specific delivery systems aim to mitigate reproductive and neural toxicity. Future directions include validating TEAD3 as a predictive biomarker and exploring combination therapies for cancer.

3. Research Significance
TEAD3’s significance spans multiple biological processes and diseases. In reproductive biology, it is indispensable for placental development and pregnancy maintenance, providing insights into pregnancy-related disorders like preeclampsia. In oncology, its tissue-specific dual roles offer precision therapeutic opportunities for gynecological, colorectal, and lung cancers.
In neuroscience, preliminary findings link TEAD3 to neural development and disorders such as schizophrenia and Alzheimer’s disease, opening new research avenues. Basic research on TEAD3 deepens understanding of transcriptional regulation and signaling crosstalk, while translational efforts advance treatments for cancer, reproductive disorders, and potential neuropsychiatric diseases—addressing unmet medical needs.

4. Molecular Mechanisms, Biological Roles, and Product Applications
4.1 Core Molecular Mechanisms of TEAD3
4.1.1 DNA Binding and Cofactor Interaction
TEAD3 binds MCAT elements via its TEA domain, with Lys52 mediating specificity. Its transcriptional activity depends on forming complexes with coactivators like YAP/TAZ through the C-terminal hydrophobic pocket. The unique 5–7-degree binding angle of the TEAD3-YAP complex confers functional specificity.

4.1.2 Post-Translational Regulation
* Palmitoylation at Cys359 (distinct from other TEADs) modulates conformational changes and transcriptional activity.
* ​Phosphorylation and SUMOylation regulate nucleocytoplasmic shuttling, protein stability, and cofactor interaction efficiency.

4.2 Biological Roles of TEAD3
4.2.1 Placental Development and Pregnancy Maintenance
TEAD3 is essential for embryonic implantation and placental development—knockout mice exhibit implantation failure and early pregnancy termination (resembling human recurrent miscarriage). It regulates trophoblast stem cell proliferation/differentiation, placental villus formation, and vascular remodeling. Single-cell analyses show TEAD3 has distinct roles: controlling cell cycle in cytotrophoblasts and hormone synthesis/nutrient transport in syncytiotrophoblasts. Aberrant expression is linked to preeclampsia and fetal growth restriction.

4.2.2 Cancer Development and Progression
TEAD3 exhibits tissue-specific duality:
Oncogenic Role: Overexpressed in ovarian, endometrial, and breast cancers (correlating with poor prognosis). Integrates Hippo and hormone receptor signaling (e.g., forms complexes with ERα to upregulate cyclin D1, c-Myc) and promotes the Warburg effect via GLUT1/HK2.
Tumor-Suppressive Role: In colorectal and certain lung cancers, competitively binds promoters to inhibit β-catenin/TCF and NF-κB pathways.

4.2.3 Nervous System Development and Function
Developmental Expression: Enriched in embryonic thalamus and hypothalamus, implicating roles in brain patterning.
Adult Brain: Localized to hippocampus and amygdala, linked to synaptic plasticity, emotional regulation, and memory.
Disease Links: GWAS associate TEAD3 locus with schizophrenia/depression; aberrant expression in Alzheimer’s hippocampus correlates with disease stage. Conditional overexpression mitigates β-amyloid-induced synaptic damage in animal models.

4.3 TEAD3-Targeted Therapeutic Strategies
Small-Molecule Inhibitors: Modified flufenamic acid derivatives bind the Cys359 palmitoylation pocket, suppressing transcriptional activity in ovarian/endometrial cancer models.
Peptide Inhibitors: Block TEAD3 interactions with YAP/ERα, preserving other functions.
Gene Therapy: ASOs and siRNA selectively regulate TEAD3 expression, inhibiting hormone-dependent tumor growth in preclinical studies.
Challenges and Solutions: Reproductive/neural toxicity (tissue-specific delivery), TEAD family homology (allosteric inhibitors), lack of biomarkers (multi-omics-based patient stratification).

4.4 How ANT BIO PTE. LTD. Products Support TEAD3 Research
ANT BIO PTE. LTD., through its sub-brand UA (specializing in recombinant proteins), provides high-quality TEAD3 proteins to advance mechanistic and translational research.
Key products and applications:
UA010707 (TEAD3 His Tag Protein, Human): E.coli-expressed full-length human TEAD3 with His tag. Ideal for DNA-binding assays (MCAT element interaction), post-translational modification studies, and screening small-molecule modulators.
UA080034 (TEAD3(YBD), His Tag Protein, Human): E.coli-expressed TEAD3 containing the YAP-binding domain (YBD). Suitable for studying TEAD3-YAP/TAZ cofactor interactions, inhibitor screening targeting protein-protein interfaces, and structural biology research.
Both products undergo rigorous quality control, ensuring high purity, biological activity, and consistency—critical for reproducible binding assays, drug screening, and signaling pathway analysis.

5. Brand Mission
ANT BIO PTE. LTD. is dedicated to empowering the global life science community with high-quality, innovative biological reagents and solutions. With 15 years of antibody development experience, the company leverages advanced platforms—including recombinant antibody development (rabbit/mouse monoclonal), recombinant protein expression systems (E.coli, CHO, HEK293, Insect Cells), One-Step ELISA, and PTM Pan-Modification Antibody platforms—to deliver a comprehensive product portfolio.

Through its three specialized sub-brands—Absin (general reagents and kits), Starter (antibodies), and UA (recombinant proteins)—ANT BIO PTE. LTD. adheres to international certifications (EU 98/79/EC, ISO9001, ISO13485) and strict quality standards. The company’s mission is to accelerate scientific discovery by providing tools that enhance experimental precision, efficiency, and reproducibility. ANT BIO PTE. LTD. is committed to supporting TEAD3 research and global efforts in cancer therapy, reproductive medicine, and neuroscience, ultimately advancing human health through interdisciplinary collaboration and innovation.

6. Related Product List

Product Code	Product Name	Product Details
UA010707	TEAD3 His Tag Protein, Human	Host: Human; Expression System: E.coli; Conjugation: Unconjugated
UA080034	TEAD3(YBD), His Tag Protein, Human	Host: Human; Expression System: E.coli; Conjugation: Unconjugated

7. AI Disclaimer
This article is AI-compiled and interpreted based on the original work. All intellectual property (e.g., images, data) of the original publication shall belong to the journal and the research team. For any infringement, please contact us promptly and we will take immediate action.
 
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.